Cerus (CERS) FCF Margin Growth (5y) (2015 - 2026)
Cerus (CERS) FCF Margin Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.66 Bn | 197.06 Bn | 7.27 Bn |
| 2 | Stryker | 126.34 Bn | 122.86 Bn | 4.50 Bn |
| 3 | Medtronic | 119.31 Bn | 110.09 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.08 Bn | 73.54 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.66 Bn | 47.40 Bn | 1.35 Bn |
| 6 | Dexcom | 35.13 Bn | 33.18 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.82 Bn | 31.71 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn |
| 9 | Steris | 23.24 Bn | 22.75 Bn | 684.20 Mn |
| 10 | Cerus | 569.60 Mn | 513.34 Mn | 29.53 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2,146.00 |
| Mar 31, 2026 | 17,650.00 |
| Dec 31, 2025 | 1,372.00 |
| Sep 30, 2025 | 88,434.00 |
| Jun 30, 2025 | -47,647.00 |
| Mar 31, 2025 | 644,811.00 |
| Dec 31, 2024 | 16,161.00 |
| Sep 30, 2024 | 622,013.00 |
| Jun 30, 2024 | 37,820.00 |
| Mar 31, 2024 | 56,240.00 |
| Dec 31, 2023 | 3,790.00 |
| Sep 30, 2023 | -746,452.00 |
| Jun 30, 2023 | 19,866.00 |
| Mar 31, 2023 | 505.00 |
| Dec 31, 2022 | 6,019.00 |
| Sep 30, 2022 | 8,019.00 |
| Jun 30, 2022 | 78,883.00 |
| Mar 31, 2022 | 9,027.00 |
| Dec 31, 2021 | 9,645.00 |
| Sep 30, 2021 | 4,813.00 |